PoliticalRepoPoliticalRepo

Netherlands · Record · Brief regering

2019Z05907

Response to the request of member Agema, made during the Regulation of Activities of December 4, 2018, about reimbursement for the drug nivolumab for cancer

concludedNetherlands· House of Representatives· NL

Introduced

26 March 2019

Last action

Status

Afgedaan

Sponsors

Subjects

Discovery layer

Source updated

19 February 2024

Summary

Response to the request of member Agema, made during the Regulation of Activities of December 4, 2018, about reimbursement for the drug nivolumab for cancer

Machine translation from Dutch. The official text remains authoritative.

Timeline

No timeline events have been ingested for this record yet.

Votes

No vote records are attached yet.

Versions

No version snapshots stored. Document URLs remain at the source.

Documents

1 official file

Reactie op het verzoek van het lid Agema, gedaan tijdens de Regeling van Werkzaamheden van 4 december 2018, over vergoeding geneesmiddel nivolumab bij vormen van kanker

View fileDownload file

  • Reactie op het verzoek van het lid Agema, gedaan tijdens de Regeling van Werkzaamheden van 4 december 2018, over vergoeding geneesmiddel nivolumab bij vormen van kanker

    Brief regering · NL · 25 March 2019

    ViewDownloadOpen at official source

Sponsors

No sponsors or actors listed by the source.

Related records

No cross-record relationships stored yet.

Sources

PoliticalRepo is an index and interpretation layer, not the authoritative legal source.